Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCT
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to determine the safety and tolerability when adding
abatacept to acute Graft versus Host Disease in transplants for malignant diseases using
unrelated donor bone marrow or peripheral blood stem cell grafts.